Level Chart

Basic Info

Thermo Fisher Scientific Inc (TMO) - Laboratory Products and Biopharma Services Operating Income is at a current level of 3.358B, up from 2.872B one year ago. This is a change of 16.92% from one year ago.

Thermo Fisher Scientific Inc Laboratory Products and Biopharma Services Operating Income represents the profit generated by its Laboratory Products and Biopharma Services segment after deducting all operating expenses associated with this specific segment.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 3.358B
Latest Period 2023
Last Updated Jan 31 2024, 12:05 EST
Next Release Jan 31 2025, 08:30 EST (E)
Average Growth Rate 14.01%
Value from 1 Year Ago 2.872B
Change from 1 Year Ago 16.92%
Frequency Yearly
Unit USD
Adjustment N/A

Historical Data

View and export this data back to 2012. Upgrade now.
Date Value
December 31, 2023 3.358B
December 31, 2022 2.872B
December 31, 2021 1.844B
December 31, 2020 1.271B
December 31, 2019 1.324B
December 31, 2018 1.258B
Date Value
December 31, 2017 1.007B
December 31, 2016 971.00M
December 31, 2015 999.00M
December 31, 2014 983.00M
December 31, 2013 960.00M
December 31, 2012 912.40M

Basic Info

Thermo Fisher Scientific Inc (TMO) - Laboratory Products and Biopharma Services Operating Income is at a current level of 3.358B, up from 2.872B one year ago. This is a change of 16.92% from one year ago.

Thermo Fisher Scientific Inc Laboratory Products and Biopharma Services Operating Income represents the profit generated by its Laboratory Products and Biopharma Services segment after deducting all operating expenses associated with this specific segment.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 3.358B
Latest Period 2023
Last Updated Jan 31 2024, 12:05 EST
Next Release Jan 31 2025, 08:30 EST (E)
Average Growth Rate 14.01%
Value from 1 Year Ago 2.872B
Change from 1 Year Ago 16.92%
Frequency Yearly
Unit USD
Adjustment N/A

Related Securities

Symbol Name Change %
TMO Thermo Fisher Scientific Inc 0.20%